Holding Mycophenolate Helps Immune Response to COVID Vaccination

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Withholding mycophenolate around the time of vaccination against SARS-CoV-2 proved safe and augmented the humoral response to vaccination among a group of patients at one center who were taking the immunosuppressive drug for a variety of rheumatic and musculoskeletal diseases (RMDs).

Previous studies have shown that use of mycophenolate attenuates the humoral response to SARS-CoV-2 vaccination, and the most up-to-date recommendations from the American College of Rheumatology on SARS-CoV-2 vaccination in patients with RMDs advise that mycophenolate should be withheld for a week after receiving the vaccine.

To understand better how withholding mycophenolate would affect immune response to SARS-CoV-2 vaccination, rheumatology fellow Caoilfhionn M. Connolly, MD, and coauthors at Johns Hopkins University, Baltimore, described in their report – published online Sept. 23, 2021, in Annals of the Rheumatic Diseases – how they compared the immune responses to vaccination in 24 patients who withheld mycophenolate and 171 patients who did not stop taking it. All but 1 of the 24 patients who withheld mycophenolate were female, with a median age of 51 years, and they had mostly systemic lupus erythematosus (6 patients), myositis (5), scleroderma (4), or overlap connective tissue disease (4). Three patients received the Janssen/Johnson & Johnson vaccine; all others received either the two-dose Moderna or Pfizer/BioNTech mRNA series.

At a median of 32 days after vaccination, all but two of the patients (92%) who withheld mycophenolate had detectable antibodies against the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, compared with 65% of those who continued the drug (P=.01). This calculated to patients who withheld the drug as having nearly sixfold higher odds for a positive antibody response (odds ratio, 5.8; 95% CI, 1.3-25.5; P=.02). The association remained statistically significant in an logistic regression analysis that was adjusted for age, sex, race, vaccine type, and use of rituximab and glucocorticoids.

The withholding group also had significantly higher median anti-RBD immunoglobulin titers than did the group that continued therapy (125 vs. 7 U/L; P=.004).

Two patients who reported a flare of their underlying disease during the perivaccination period were treated with topical and oral glucocorticoids.

The patients who withdrew mycophenolate had taken it with twice daily dosing at a median total daily dose of 2,000 mg. They ended up withholding a median of 20 doses around the time of vaccination, with 54% withholding before, 38% both before and after, and 8% only after vaccination.

The researchers said that the conclusions that can be drawn from the study were limited by its small sample size, which “did not allow for evaluation of optimal duration of withholding therapy,” and also its “nonrandomized design, lack of data on cellular response, and limited information on dosing of other immunosuppressive agents.”

Three of the authors disclosed receiving consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, and Thermo Fisher Scientific. A fourth author has received consulting fees from Janssen, Boehringer Ingelheim, Mallinckrodt, EMD Serono, Allogene, and ArgenX.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
הר"י מאיימת בשביתה: "חיי הצוותים הרפואיים לא יהיו להפקר" thumbnail

הר”י מאיימת בשביתה: “חיי הצוותים הרפואיים לא יהיו להפקר”

ההסתדרות הרפואית הודיעה אמש (א') על סכסוך עבודה בכל המערכת האשפוזית במחאה על תופעת האלימות במערכת ועל רקע המקרה החמור מסוף השבוע האחרון של פגיעה קשה ואלימה ברופא נשים בחדר המיון של בית החולים איכילוב בתל אביב. יו"ר ההסתדרות הרפואית, פרופ' ציון חגי, הבהיר כי הסכסוך יופעל ברגע שתורגש ירידה בתחלואת הקורונה, לרבות שביתה של…
Read More
“The ball is clearly with Switzerland” - the new EU manager for Switzerland formulates clear expectations thumbnail

“The ball is clearly with Switzerland” – the new EU manager for Switzerland formulates clear expectations

Das Dossier Schweiz ist bei der EU künftig beim Vizepräsidenten der Europäischen Kommission, Maros Sefcovic, angesiedelt und nicht mehr bei der Präsidentin Ursula von der Leyen. Der Slowake erwartet jetzt Lösungsvorschläge von der Schweiz. Ein neuer Ansprechpartner für Ignazio Cassis bei der EU: Maros Sefcovic übernimmt das Schweiz-Dossier. Francisco Seco / ReutersDer erwartete Wechsel der…
Read More
포천 베어스타운 스키장서 리프트 역주행…100여명 한때 공중에 고립 thumbnail

포천 베어스타운 스키장서 리프트 역주행…100여명 한때 공중에 고립

22일 오후 3시쯤 경기 포천시 베어스타운 스키장에서 슬로프 정상을 향해 올라가던 리프트가 갑자기 역주행하는 사고가 발생했다. 신고를 받고 출동한 소방대는 리프트에 탄 탑승객을 구조했다. 연합뉴스 경기도 포천의 베어스타운 스키장에서 리프트가 역주행하는 사고가 22일 발생했다. 경찰과 소방당국에 따르면 이날 오후 3시쯤 슬로프 정상을 향해 올라가던 리프트가 잠시 멈추듯 하더니 갑자기 뒤로 미끄러져 내리기 시작했다. 리프트가 움직이자…
Read More
Make-up of gut microbiome may be linked to long COVID risk thumbnail

Make-up of gut microbiome may be linked to long COVID risk

Image of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDC The make-up of the gut microbiome may be linked to a person's risk of developing 'long COVID' many months after initial infection with SARS-CoV-2, the virus responsible for COVID-19 infection, suggests research published online in the journal Gut. Microbiome 'profiling' might…
Read More
Managing Refractory Gastroparesis: AGA Clinical Practice Update thumbnail

Managing Refractory Gastroparesis: AGA Clinical Practice Update

Gastroparesis can be tricky to diagnose and treat, in part because its symptoms can be difficult to distinguish from functional dyspepsia. A new clinical practice update from the American Gastroenterological Association aims to help physicians treat medically refractory gastroparesis with practical advice stemming from expert opinion and a literature review. Although gastroparesis can be caused…
Read More
Index Of News
Total
0
Share